IDYA - IDEAYA nabs Fast Track status for ovarian cancer candidate
2023-09-26 09:43:37 ET
More on IDEAYA Biosciences
- IDEAYA's Triple Threat: Melanoma, Money, And Momentum
- Ideaya Biosciences: Eye Cancer Therapy Drives Gains - More Upside Ahead
- IDEAYA wins key milestone in GSK deal as FDA clears cancer trial
- Seeking Alpha’s Quant Rating on IDEAYA Biosciences
For further details see:
IDEAYA nabs Fast Track status for ovarian cancer candidate